Prevalence of antinuclear antibodies in 3 groups of healthy individuals: Blood donors, hospital personnel, and relatives of patients with autoimmune diseases

Journal of Clinical Rheumatology

Volumn 15, Issue 7, 2009, Pages 325-329

  Marin, Guadalupe G ^a   Cardiel, Mario H ^b   Cornejo, Horacio ^b   Viveros, Martha E ^a,c  

^a UNIVERSIDAD MICHOACANA DE SAN NICOLÁS DE HIDALGO   (Mexico)

^b HOSPITAL GENERAL DR MIGUEL SILVA   (Mexico)

^c Division de Posgrado   (Mexico)

Author keywords

Antinuclear antibodies; Healthy individuals; Prevalence

Indexed keywords

ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HEP 2 CELL; HOSPITAL PERSONNEL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MEXICO; NORMAL HUMAN; PRIORITY JOURNAL; RELATIVE; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; BLOOD DONORS; CHILD; FAMILY; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEXICO; MIDDLE AGED; PERSONNEL, HOSPITAL; PREVALENCE; YOUNG ADULT;

EID: 70350135961     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/RHU.0b013e3181bb971b     Document Type: Article

References (39)

1. Vlachoyiannopoulos PG, Tzavara V, Dafni U, et al. Clinical features and evolution of antinuclear antibody positive individuals in a rheumatology outpatient clinic. J Rheumatol. 1998;25:886-891.
2. Tozzoli R, Bizzaro N, Tonutti E, et al. Guidelines for Laboratory use of autoantibody test in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol. 2002;117:316-324.
3. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25: 1271-1277.
4. Comby E, Tanaff P, Mariotte D, et al. Evolution of antinuclear antibodies and clinical patterns in patients with active rheumatoid arthritis with long-term infliximab therapy. J Rheumatol. 2006;33:24-30.
5. Satoh M, Chan EKL, Sobel ES, et al. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol. 2007;3:721-738.
6. Yoshida H, Imafuku Y, Morita EQ, et al. Detection of antinuclear antibodies and their significance as disease markers. Rhinho Byori. 1994;42:455-459.
7. Keren DF. Antinuclear antibody Testing. Clin Lab Med. 2002;22:447-474.
8. McGhee JL, Kickingbird LM, Jarvis JN. Clinical utility of antinuclear antibody tests in children. BMC Pediatr. 2004;4:13.
9. Myckatyn SO, Russell AS. Outcome of positive antinuclear antibodies in individuals without connective tissue disease. J Rheumatol. 2003;30:736-739.
10. Peene I, Meheus L, Veys EM, et al. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis. 2001;60:1131-1136.
11. Cabral DA, Petty RE, Fung M, et al. Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease. Pediatrics. 1992;89:441-444.
12. Deane PM, Liard G, Siegel DM, et al. The outcome of children referred to a pediatric rheumatology clinic with a positive antinuclear antibody test but without an autoimmune disease. Pediatrics. 1995;95:892-895.
13. Tan EM, Feltkamp TE, Smolen JS, et al. Range of antinuclear antibodies in "healthy" individuals. Arth Rheum. 1997;40:1601-1611.
14. Chaiamnuay P, Johnston C, Maier J, et al. Technique-related variation in results of ANA tests. Ann Rheum Dis. 1984;43:755-757.
15. Binder SR. Autoantibody detection using multiplex technologies. Lupus. 2006;15:412-421.
16. Kern P, Kron M, Hiesche K. Measurement of antinuclear antibodies: assessment of different test systems. Clin Diagn Lab Immunol. 2000;7:72-78.
17. Solomon DH, Kavanaugh AJ, Schur PH. Evidence-based guidelines for the use of immunologic test: antinuclear antibody testing. Arthritis Rheum. 2002;47:434-434
18. Satoh M, Vazquez del Mercado M, Chan EK. Clinical interpretation of antinuclear antibody tests in systemic rheumatic diseases. Mod Rheumatol. March 2009;19:219-228.
19. Pollock W, Toh BH. Routine immunofluorescence detection of Ro/SS-A autoantibody using HEp-2 cell transfected with human 60 kDa Ro/SS-A. J Clin Pathol. 1999;52:684-687.
20. Hoffman IE, Peene I, Veys EM, et al. Detection of specific antinuclear reactivities in patients with negative anti-nuclear antibody immunofluorescence screening tests. Clin Chem. 2002;48:2171-2176.
21. Vaile JH, Dyke L, Kherani R, et al. Is high titer ANA specific for connective tissue disease? Clin Exp Rheumatol. 2000;18:433-438.
22. Narain S, Richards HB, Satoh M, et al. Diagnostic accuracy for lupus and other systemic autoimmune diseases in the community setting. Arch Intern Med. 2004;164:2435-2441.
23. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med. 2003;349:1526-1533.
24. Heinlen LD, Mcclain MT, Kim X, et al. Anti-Ro and anti-RNPn responses in unaffected family members of SLE patients. Lupus. 2003;12:335-337.
25. Alarcón-Segovia D, Alarcón-Riquelme ME, Cardiel MH, et al; Grupo Latinoamericano de Estudio del Lupus Eritematoso (GLADEL). Familial aggregation of systemic lupus erythematosus, rheumatoid arthritis, and other autoimmune diseases in 1,177 lupus patients from the GLADEL cohort. Arthritis Rheum. 2005;52:1138-1147.
26. Corporaal S, Bijl M, Kallenberg CG. Familial occurrence of autoimmune disease and autoantibodies in a caucasican population of patients with systemic lupus erythematosus. Clin Rheumatol. 2002;21:108-113.
27. Laustrup H, Heegaard NH, Voss A, et al. Autoantibodies and self-reported health complaints in relatives of systemic lupus erythematosus patients: a community based approach. Lupus. 2004;13:792-799.
28. Aho K, Koskela P, Makitalo R, et al. Antinuclear antibodies heralding the onset of systemic lupus erythematosus. J Rheumatol. 1992;19:1377-1379.
29. Zarmbinksi MA, Messner RP, Mandel JS. Anti-dsDNA antibodies in laboratory workers handling blood from patients with systemic lupus erythematosus. J Rheumatol. 1992;19:1380-1384.
30. Rosenberg AM, Semchuk KM, McDuffie HH, et al. Prevalence of antinuclear antibodies in a rural population. J Toxicol Environ Health A. 1999;57:225-236.
31. Parks CG, Cooper GS. Occupational exposures and risk of systemic lupus erythematosus: a review of the evidence and exposure assessment methods in population-and clinic-based studies. Lupus. 2006;15:728-736.
32. Semchuk KM, Rosenberg AM, McDuffie HH, et al. Antinuclear antibodies and Bromoxynil exposure in a rural sample. Toxicol Environ Health. 2007; 70:638-657.
33. Esteves MO, Len CL, Campos Roja S, et al. Frequency of antinuclear antibodies in healthy children and adolescents. Clin Pediatr. 2004;43:637-642.
34. Wananukul S, Voramethkul W, Kaewopas Y, et al. Prevalence of positive antinuclear antibodies in healthy children. Asian Pac J Allergy Immunol. 2005;23:153-157.
35. Arcavi M, Orfus G. Prevalencia de anticuerpos anti envoltura nucleary sus isotipos en sueros positivos para anticuerpos antinucleares. Medicina (B Aires). 2006;66:327-333.
36. Makinodan T, Kay MMB. Age influence on the immune system. Adv Immunol. 1980;29:287-330.
37. Ioannidis JP, Katsifis GE, Stavropoulos ED, et al. Evaluation of the association of autoantibodies with mortality in the very elderly: a cohort study. Rheumatology. 2003;42:357-361.
38. Nilsson BO, Skogh T, Ernerudh J, et al. Anitnuclear antibodies in the oldest-old women and men. J Autoimmun. 2006;27:281-288.
39. Fernandez SA, Lobo AZ, Prado De Olveira ZN, et al. Prevalence of antinuclear autoantibodies in the serum of normal blood donors. Rev Hosp Clín Fac Med Sao Paulo. 2003;58:315-319.